A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma

LESSONS LEARNED. Pazopanib shows a modest efficacy in metastatic alveolar soft part sarcoma. Clinical outcomes were comparable to those in previous studies using antiangiogenic drugs. Further prospective studies evaluating the benefit of pazopanib in alveolar soft part sarcoma with a larger sample a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Kim, Miso, Kim, Tae Min, Keam, Bhumsuk, Kim, Yu Jung, Paeng, Jin Chul, Moon, Kyung Chul, Kim, Dong‐Wan, Heo, Dae Seog
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2018
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324645/
https://ncbi.nlm.nih.gov/pubmed/30254189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0464
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires